Variant report
Variant | esv3334718 |
---|---|
Chromosome Location | chr10:1455483-1455918 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:1448874..1450654-chr10:1453842..1455839,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371911898 | chr10:1455520-1455521 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572021116 | chr10:1455523-1455524 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529275338 | chr10:1455539-1455540 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2255595 | chr10:1455543-1455544 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576337241 | chr10:1455544-1455545 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540580980 | chr10:1455545-1455546 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113674938 | chr10:1455552-1455553 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572025946 | chr10:1455609-1455610 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541155955 | chr10:1455631-1455632 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564118482 | chr10:1455661-1455662 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112696988 | chr10:1455695-1455696 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528377961 | chr10:1455725-1455726 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543647672 | chr10:1455737-1455738 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1806447 | chr10:1455766-1455767 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529222639 | chr10:1455771-1455772 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141700615 | chr10:1455777-1455778 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1806446 | chr10:1455810-1455811 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs145577727 | chr10:1455811-1455812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371798128 | chr10:1455816-1455817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547915262 | chr10:1455829-1455830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536786296 | chr10:1455870-1455871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111560954 | chr10:1455872-1455873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566947627 | chr10:1455892-1455893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 20409316 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Cancer | 21129771 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Wilms tumour | 19047088 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Barakat syndrome | 22470819 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Autism | 18414403 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Breast cancer | 22032731 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 17363583 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:1443600-1456000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr10:1451800-1461600 | Weak transcription | Gastric | stomach |
3 | chr10:1454000-1456000 | Enhancers | Primary B cells from cord blood | blood |
4 | chr10:1454800-1455600 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr10:1455200-1455800 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
6 | chr10:1455400-1459000 | Weak transcription | Dnd41 | blood |
7 | chr10:1455600-1459800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |